ClinicalTrials.govpublic full text
An Open-Label, Double-Treatment Group Study to Evaluate the Efficacy and Safety of Human Allogeneic Bone-Marrow- Derived Mesenchymal Stromal Cell Product StromaForte Compared With Hyaluronic Acid for the Treatment of Knee Osteoarthritis
knee arthritis osteoarthritis, cellcolabs, knee oa, mesenchymal stem cells, cell therapy, interventional, phase2, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 892645
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.